- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
The 2023 American Society of Hematology (ASH) Annual Meeting and Exposition saw more than 7000 abstracts, with a focus placed on real-world data and practice-changing updates. A major theme of this year's meeting was a timely one: What can clinicians and researchers do to close persistent disparities in care and foster health equity?
An area of great need is multiple myeloma, with outcomes still far worse among Black patients in the United States compared with White patients despite potentially favorable cytogenetic disease characteristics and a plethora of novel treatments that have improved multiple myeloma outcomes overall.
In today's episode, Raymond Thertulien, MD, PhD, director of multiple myeloma and plasma cell disorders at Novant Health, is joined by Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, to discuss ASH 2023 data and the drivers of racial disparities in multiple myeloma outcomes. They spoke on a range of topics, including unacceptable gaps in access to the latest treatments, underuse of diagnostics such as cytogenetic testing, and society-level barriers to equitable care for Black patients with multiple myeloma.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More
